Together, three representative compounds ( Quercetin, Luteolin and Baicalein) of HD–SB could bind well to four core targets of HCC (P53, CDK2, XPO1 and APP), all of which could play key roles in the treatment of HCC. Here, APP is linked to hepatocellular carcinoma.